Abstract:Metabolic syndrome accelerates the atherosclerotic process, and the earliest event of which is endothelial dysfunction. Ghrelin, a newly discovered gastric peptide, improves endothelial function and inhibits proatherogenic changes. In particular, low ghrelin concentration has been associated with several features of metabolic syndrome, including obesity, insulin resistance, and high blood pressure. However, the molecular mechanisms underlying ghrelin vascular actions remain largely unclear. Here, we showed that ghrelin activated endothelial nitric oxide (NO) synthase (eNOS) in cultured endothelial cells (ECs) and in intact vessels. Specifically, ghrelin rapidly induced phosphorylation of eNOS on an activation site and production of NO in human umbilical vein ECs and bovine aortic ECs. The eNOS phosphorylation was also observed in mouse aortas ex vivo perfused with ghrelin and in aortic tissues isolated from mice injected with ghrelin. Mechanistically, ghrelin stimulated AMP-activated protein kinase (AMPK) and Akt activation in cultured ECs and intact vessels. Inhibiting AMPK and Akt with their pharmacological inhibitors, small interference RNA and adenoviruses carried dominant-negative mutants, markedly attenuated ghrelin-induced eNOS activation, and NO production. Furthermore, ghrelin receptor/Gq protein/ calcium-dependent pathway mediates activation of AMPK, Akt, and eNOS, and calmodulin-dependent kinase kinase is a potential convergent point to regulate Akt and AMPK activation in ghrelin signaling. Importantly, eNOS activation is critical for ghrelin inhibition of vascular inflammation. Together, both in vitro and in vivo data demonstrate a new role of ghrelin signaling for eNOS activation, and highlight the therapeutic potential for ghrelin to correct endothelial dysfunction associated with atherosclerotic vascular diseases and metabolic syndrome.

The New Mechanism of Ghrelin/GHSR-1a on Autophagy Regulation

Ghrelin inhibited pressure overload-induced cardiac hypertrophy by promoting autophagy via CaMKK/AMPK signaling pathway

Ghrelin: a Journey from GH Secretagogue to Regulator of Metabolism

Potential New Role of the GHSR-1a-mediated Signaling Pathway in Cardiac Remodeling after Myocardial Infarction (Review)

Potential new role of the GHSR-1a-mediated signaling pathway in cardiac remodeling after myocardial infarction (Review).

Molecular Mechanisms of Ghrelin-Mediated Endothelial Nitric Oxide Synthase Activation

Ghrelin Promotes and Protects Nigrostriatal Dopamine Function Via a UCP2-dependent Mitochondrial Mechanism.

Ghrelin As a Treatment for Cardiovascular Diseases

Potential role of ghrelin in the regulation of inflammation

Ghrelin Attenuated Lipotoxicity Via Autophagy Induction and Nuclear Factor-κB Inhibition

Ghrelin Protects Heart Against ERS-induced Injury and Apoptosis by Activating AMP-activated Protein Kinase

Ghrelin Signaling: GOAT and GHS-R1a Take a LEAP in Complexity

Ghrelin Stimulates Endothelial Cells Angiogenesis Through Extracellular Regulated Protein Kinases (Erk) Signaling Pathway

Ghrelin and the heart

Therapeutic potential of ghrelin/GOAT/GHSR system in gastrointestinal disorders

Effect of Ghrelin on the Cardiovascular System

Ghrelin in Focus: Dissecting Its Critical Roles in Gastrointestinal Pathologies and Therapies

Effect of Ghrelin on Energy Metabolism in Chronic Heart Failure

Ghrelin and the cardiovascular system

The Treatment of Ghrelin on Cardiac Cachexia in Congestive Heart Failure

Emerging Relevance of Ghrelin in Programmed Cell Death and Its Application in Diseases